Aspirin rarely used for colorectal cancer prevention

Дата публикации: 11-10-2026 00:30:05

People with Lynch syndrome have a significantly increased risk of developing colorectal cancer and other types of cancer due to a hereditary predisposition. The CAPP2 study had already shown in this high-risk group that acetylsalicylic acid can significantly reduce the long-term risk of colorectal cancer. The study examined a comparatively high daily dose of 600 milligrams. The recently published international CaPP3 study now suggests that even a lower dose of 100 milligrams daily could have a similar cancer-preventive effect while causing fewer side effects, particularly bleeding complications. The research is published in The Lancet Gastroenterology & Hepatology journal.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Millions take aspirin to prevent colon cancer. A major review says don’t count on it	0	7.08	04-03-2026
2	Ученые: аспирин может быть эффективен в борьбе с некоторыми видами рака	0	0	27-09-2018
3	AI Not Automatically Better for Colorectal Cancer Screening Lancet study from Bonn on Lynch syndrome	0	7	17-07-2026
4	Оценка модифицируемых факторов риска предраковых заболеваний толстой кишки	0	5	18-06-2026
5	Long-term alcohol use linked to a sharp rise in rectal cancer	0	8.31	29-01-2026
6	KI verbessert Darmkrebsvorsorge nicht automatisch Lancet-Studie aus Bonn zu Menschen mit Lynch-Syndrom	0	7	17-07-2026
7	Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery	0	5	06-07-2026
8	Parental factors may affect early-onset colorectal cancer risk	0	12.14	22-07-2026
9	Trial suggests less frequent colonoscopies may safely follow removal of high-risk polyps	0	12.8	17-09-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 10.01. Источник: medicalxpress.com.